$IRWD Income Statement | Understand Stock

$IRWD

$3.51 +$0.01 (0.29%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating Income (Loss)
Revenues
Collaborative arrangements revenue
Sale of active pharmaceutical ingredient
Total revenues

Costs and expenses:
Research and development
Selling, general and administrative
Restructuring, net
Acquired in-process research and development
Total costs and expenses
Income from operations
Other income (expense):
Interest expense and other financing costs
Interest and investment income
Gain on derivatives
Other
Other income (expense), net
Income before income taxes
Income tax expense
Income from continuing operations
Net income (loss)
Less: Net loss attributable to noncontrolling interests
Net income
Comprehensive income
Income per share from continuing operations, net of income taxes - basic (in dollars per share)
Income per share from continuing operations, net of income taxes - diluted (in dollars per share)
Net income per share - basic (in dollars per share)
Net income per share - diluted (in dollars per share)
Weighted average shares used in computing net income per share - basic (in shares)
Weighted average shares used in computing net income per share - diluted (in shares)

Comments